Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	121
Overall Study	STARTED	Lacosamide	121
Overall Study	Completed Treatment Period	Placebo	110
Overall Study	Completed Treatment Period	Lacosamide	103
Overall Study	Enrolled Transition Period	Placebo	108
Overall Study	Enrolled Transition Period	Lacosamide	101
Overall Study	Enrolled Taper Period	Placebo	7
Overall Study	Enrolled Taper Period	Lacosamide	9
Overall Study	Enrolled Safety Folllow-up Period	Placebo	10
Overall Study	Enrolled Safety Folllow-up Period	Lacosamide	11
Overall Study	COMPLETED	Placebo	110
Overall Study	COMPLETED	Lacosamide	103
Overall Study	NOT COMPLETED	Placebo	11
Overall Study	NOT COMPLETED	Lacosamide	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02408523/flow